Common TitleSofosbuvir-Velpatasvir in Patients with Decompensated Cirrhosis Study (Japan)
Official Title Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial
Phase Phase III
Treatments
Sofosbuvir-Velpatasvir
Sofosbuvir-Velpatasvir
Tradename:EpclusaOther Names:SOF-VELClass:FDA-ApprovedFunding
IndustryGilead Sciences